Related Experiment Videos
[Familial Mediterranean fever, complement, cryofibrinogen, colchicine (author's transl)]
Annales De Medecine Interne
|January 1, 1981
Summary
Familial Mediterranean Fever (FMF) patients showed increased complement components C4, C2, and C3. Cryofibrinogenemia, a condition involving fibrin, fibrinogen, and fibronectin, was observed in 42% of patients and reduced by colchicine treatment.
Area of Science:
- Immunology
- Rheumatology
- Hematology
Context:
- Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disorder.
- Complement system activation is implicated in FMF pathogenesis.
- Cryofibrinogenemia involves abnormal protein precipitation in the blood.
Purpose:
- To investigate complement system component levels in FMF patients.
- To determine the prevalence and composition of cryofibrinogenemia in FMF.
- To assess the effect of colchicine on cryofibrinogenemia in FMF.
Summary:
- Complement components C4, C2, and C3 were elevated in 24 FMF patients.
- Cryofibrinogenemia was detected in 42% of FMF patients, comprising fibrin, fibrinogen, and fibronectin.
- Colchicine treatment was associated with a reduced incidence of cryofibrinogenemia (p < 0.02).
Impact:
- Provides insights into the role of the complement system in FMF.
- Highlights cryofibrinogenemia as a potential biomarker or associated condition in FMF.
- Suggests a potential mechanism for colchicine's therapeutic effect in FMF.